We outline some big takeaways, likely outcomes, improbable outliers, and prudent strategies for investors anxiously following the fiscal cliff drama.
Experience and expertise keep projects on time and on budget, says CFO Pat Reddy.
Rising input costs and global food consumption will be key factors in the coming years for agriculture-related stocks, according to Morningstar's Adam Fleck.
Dave Ricks, head of Lilly's Bio-Medicines group, discusses the pharma giant's competitive advantages with Morningstar's Damien Conover.
©2012 Morningstar Advisor. All right reserved.